Home / Tag Archives: diabetes biomarkers (page 2)

Tag Archives: diabetes biomarkers

A Positive Type 1 Diabetes Screen Isn’t Always Equal: Why IA-2 Changes the Risk Calculation

Clinical illustration showing IA-2 autoantibody testing, type 1 diabetes risk assessment, blood sample analysis, and patient monitoring strategies used in islet autoantibody screening risk stratification.

As population-based screening for type 1 diabetes (T1D) becomes more common, clinicians increasingly encounter positive islet autoantibody results in children and adults who have no symptoms. However, not all positive screening results carry the same clinical significance. A single positive autoantibody may indicate elevated risk, yet the specific antibody detected …

Read More »

When A1C Improves but the Patient Doesn’t: Rethinking What “Good Control” Really Means

Older woman with diabetes reviewing improved A1C results while appearing fatigued and emotionally overwhelmed at home

Improving hemoglobin A1C has long been considered the gold standard in diabetes care. However, many clinicians now question whether lower numbers always translate into healthier, happier patients. The growing debate over how A1C levels relate to real-world diabetes outcomes highlights an important issue in modern medicine: a patient can achieve …

Read More »